enow.com Web Search

  1. Ads

    related to: is plan b fda approved drug for macular degeneration patients

Search results

  1. Results from the WOW.Com Content Network
  2. Avacincaptad pegol - Wikipedia

    en.wikipedia.org/wiki/Avacincaptad_pegol

    Avacincaptad pegol, sold under the brand name Izervay, is a medication used for the treatment of age-related macular degeneration. [1] Avacincaptad pegol is a complement inhibitor. [1] Avacincaptad pegol was approved for medical use in the United States in August 2023. [2] [3] [4]

  3. Pegaptanib - Wikipedia

    en.wikipedia.org/wiki/Pegaptanib

    Pegaptanib [2] sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). [3] It was discovered by NeXstar Pharmaceuticals (which merged with Gilead Sciences in 1999) and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States.

  4. Anti-VEGF - Wikipedia

    en.wikipedia.org/wiki/Anti-VEGF

    Off-label use of intravitreal bevacizumab has become a widespread treatment for neovascular age-related macular degeneration. [11] Although the drug is not FDA-approved for non-oncologic uses, some studies [which?] suggest that bevacizumab is effective in increasing visual acuity with low rates of ocular adverse effects. However, due to small ...

  5. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/fda-approves-biosimilars-macular...

    The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related macular degeneration, diabetic retinopathy and other eye conditions.

  6. Regeneron Wins FDA Approval for Macular-Degeneration Drug - AOL

    www.aol.com/news/2011-11-19-regeneron-wins-fda...

    Tarrytown, N.Y.-based Regeneron said yesterday it has gotten clearance from the FDA to start selling afilbercept. The folks at Regeneron Pharmaceuticals (NAS: REGN) are going to have a happy ...

  7. Conbercept - Wikipedia

    en.wikipedia.org/wiki/Conbercept

    Conbercept, sold under the commercial name Lumitin, is a novel vascular endothelial growth factor (VEGF) inhibitor used to treat neovascular age-related macular degeneration (AMD) [1] [2] and diabetic macular edema (DME). [3] The anti-VEGF was approved for the treatment of neovascular AMD by the China State FDA (CFDA) in December 2013.

  8. List of drugs granted breakthrough therapy designation

    en.wikipedia.org/wiki/List_of_drugs_granted...

    To treat geographic atrophy secondary to age-related macular degeneration [1] Leqembi: To treat Alzheimer's disease [1] Loqtorzi: To treat recurrent or metastatic nasopharyngeal carcinoma with or following other therapies [1] Ogsiveo: To treat desmoid tumors [1] Pombiliti: To treat late-onset Pompe disease with miglustat [1] Rivfloza

  9. What is Plan B birth control? How do morning after pills work ...

    www.aol.com/plan-b-birth-control-morning...

    Plan B One-Step is not the same as the abortion pill and will not affect an existing pregnancy, according to the FDA. The abortion pill involves two different drugs called mifepristone and ...

  1. Ads

    related to: is plan b fda approved drug for macular degeneration patients